. . . . . . . . . . "bp(GOBP:\"inflammatory response\") -> path(SDIS:neurodegeneration)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Collectively, the data covered in this review article suggest that CNS-confined inflammation in MS is associated with the release of soluble molecules, which are capable of altering excitatory synaptic transmission and, finally, of stimulating secondary neurodegenerative gray matter pathology" . . "Selventa" . . . . "2014-07-03T14:33:37.537+02:00"^^ . . .